• Congratulations on the #12th International Course on Coronary Computational Physiology came to a successful conclusion. #μFR
    July 1, 2022
    #Global Computational Coronary Physiology Training Center # Fuwai Hospital, #CAMS&PUMC #Pulse...
    Pulse's μFR Improved Clinical Outcomes and Saved Costs Over 1 Year in FAVOR III China Trial
    May 28, 2022
    Follow us at LinkedIn: Pulse Medical and  Twitter: @PulseMedTech Quantitative flow ratio ...
    Join us in Paris for #EuroPCR 2022 
    May 10, 2022
    Join the "Pulse Medical Scientific Programe" to learn the progress of μFR, the evidence-based new...
    OFR was approved by China FDA (NMPA)
    December 2, 2021
    Image from NMPA official website  November 10th 2021, News from Shanghai, China.  China...
    LANCET: Pulse μFR guided PCI resulted in a 35% reduction of MACE at one year follow-up
    November 5, 2021
      On November 4, 2021, The findings of FAVOR III China were published in The Lacent（Impact...
    Pulse Medical raises over $100M to improve precision pan-vascular interventional diagnostics
    August 5, 2021
    Shanghai Pulse Medical Technology, Inc.has raised more than $100 million in a series C funding...
    OFR (World’s First OCT-Based FFR) Receives CE Mark!
    April 26, 2020
    OFR (World’s First OCT-Based FFR) Receives CE Mark! Pulse Medical (Pulse Medical Imaging...
    Excellent Feedback from the 1st International Course on “Coronary Image Analysis and Computational Physiology”
    July 5, 2019
    Excellent Feedback from the 1st International Course on “Coronary Image Analysis and...
    China FDA (NMPA) approval
    July 26, 2018
    China FDA (NMPA) approval In July 18th 2018, the official website of China Food and Drug...
    More Posts
    All Posts
    ×
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More